From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)
Country
Ovaleap® (n = 153)
Gonal-f® (n = 146)
Total (N = 299)
Belgium + Germanya
35
30
65
Czech Republic
28
58
Hungary
39
38
77
Poland
49
50
99